Covid-19 Impact on Blinatumomab Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Blinatumomab, including the following market information:
Major competitors identified in this market include Amgen, etc.
Based on the Region:
- Global Blinatumomab Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
- Global Blinatumomab Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
- Global Blinatumomab Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
- Global Blinatumomab Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)
Major competitors identified in this market include Amgen, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Prefilled
- Non-prefilled
- Hospital
- Pharmacy
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Blinatumomab Industry
1.7 COVID-19 Impact: Blinatumomab Market Trends
2 GLOBAL BLINATUMOMAB QUARTERLY MARKET SIZE ANALYSIS
2.1 Blinatumomab Business Impact Assessment - COVID-19
2.1.1 Global Blinatumomab Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Blinatumomab Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Blinatumomab Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 Global Blinatumomab Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Blinatumomab Factory Price by Manufacturers
3.3 Location of Key Manufacturers Blinatumomab Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Blinatumomab Market
3.5 Key Manufacturers Blinatumomab Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON BLINATUMOMAB SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Prefilled
1.4.2 Non-prefilled
4.2 By Type, Global Blinatumomab Market Size, 2019-2021
4.2.1 By Type, Global Blinatumomab Market Size by Type, 2020-2021
4.2.2 By Type, Global Blinatumomab Price, 2020-2021
5 IMPACT OF COVID-19 ON BLINATUMOMAB SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Hospital
5.5.2 Pharmacy
5.2 By Application, Global Blinatumomab Market Size, 2019-2021
5.2.1 By Application, Global Blinatumomab Market Size by Application, 2019-2021
5.2.2 By Application, Global Blinatumomab Price, 2020-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Amgen
7.1.1 Amgen Business Overview
7.1.2 Amgen Blinatumomab Quarterly Production and Revenue, 2020
7.1.3 Amgen Blinatumomab Product Introduction
7.1.4 Amgen Response to COVID-19 and Related Developments
8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Blinatumomab Supply Chain Analysis
8.1.1 Blinatumomab Supply Chain Analysis
8.1.2 Covid-19 Impact on Blinatumomab Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Blinatumomab Distribution Channels
8.2.2 Covid-19 Impact on Blinatumomab Distribution Channels
8.2.3 Blinatumomab Distributors
8.3 Blinatumomab Customers
9 KEY FINDINGS
10 APPENDIX
10.1 About Us
10.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Blinatumomab Industry
1.7 COVID-19 Impact: Blinatumomab Market Trends
2 GLOBAL BLINATUMOMAB QUARTERLY MARKET SIZE ANALYSIS
2.1 Blinatumomab Business Impact Assessment - COVID-19
2.1.1 Global Blinatumomab Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Blinatumomab Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Blinatumomab Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 Global Blinatumomab Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Blinatumomab Factory Price by Manufacturers
3.3 Location of Key Manufacturers Blinatumomab Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Blinatumomab Market
3.5 Key Manufacturers Blinatumomab Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON BLINATUMOMAB SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Prefilled
1.4.2 Non-prefilled
4.2 By Type, Global Blinatumomab Market Size, 2019-2021
4.2.1 By Type, Global Blinatumomab Market Size by Type, 2020-2021
4.2.2 By Type, Global Blinatumomab Price, 2020-2021
5 IMPACT OF COVID-19 ON BLINATUMOMAB SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Hospital
5.5.2 Pharmacy
5.2 By Application, Global Blinatumomab Market Size, 2019-2021
5.2.1 By Application, Global Blinatumomab Market Size by Application, 2019-2021
5.2.2 By Application, Global Blinatumomab Price, 2020-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Amgen
7.1.1 Amgen Business Overview
7.1.2 Amgen Blinatumomab Quarterly Production and Revenue, 2020
7.1.3 Amgen Blinatumomab Product Introduction
7.1.4 Amgen Response to COVID-19 and Related Developments
8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Blinatumomab Supply Chain Analysis
8.1.1 Blinatumomab Supply Chain Analysis
8.1.2 Covid-19 Impact on Blinatumomab Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Blinatumomab Distribution Channels
8.2.2 Covid-19 Impact on Blinatumomab Distribution Channels
8.2.3 Blinatumomab Distributors
8.3 Blinatumomab Customers
9 KEY FINDINGS
10 APPENDIX
10.1 About Us
10.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Blinatumomab Assessment
Table 9. COVID-19 Impact: Blinatumomab Market Trends
Table 10. COVID-19 Impact Global Blinatumomab Market Size
Table 11. Global Blinatumomab Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Blinatumomab Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Blinatumomab Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Blinatumomab Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Blinatumomab Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Blinatumomab Market Growth Drivers
Table 17. Global Blinatumomab Market Restraints
Table 18. Global Blinatumomab Market Opportunities
Table 19. Global Blinatumomab Market Challenges
Table 20. Key Manufacturers Blinatumomab Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Blinatumomab Market Size, 2019 (K Units) & (US$ Million)
Table 22. Blinatumomab Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Blinatumomab Manufacturing Plants
Table 24. Key Manufacturers Blinatumomab Market Served
Table 25. Date of Key Manufacturers Enter into Blinatumomab Market
Table 26. Key Manufacturers Blinatumomab Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Blinatumomab Market Size by Type, 2020, (US$ Million)
Table 29. Global Blinatumomab Market Size by Type, 2020 (K Units)
Table 30. Global Blinatumomab Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Blinatumomab Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Blinatumomab Market Size by Application, 2020-2021 (K Units)
Table 33. Global Blinatumomab Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Blinatumomab Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Blinatumomab Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Blinatumomab Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Blinatumomab Market Size, 2019-2021 (K Units)
Table 38. US Blinatumomab Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Blinatumomab Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Blinatumomab Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Blinatumomab Market Size, 2019-2021 (K Units)
Table 43. Germany Blinatumomab Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Blinatumomab Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Blinatumomab Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Blinatumomab Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Blinatumomab Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Blinatumomab Market Size, 2019-2021 (K Units)
Table 50. China Blinatumomab Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Blinatumomab Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Blinatumomab Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Blinatumomab Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Blinatumomab Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Blinatumomab Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Blinatumomab Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. Amgen Business Overview
Table 58. Amgen Blinatumomab Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Amgen Blinatumomab Product
Table 60. Amgen Response to COVID-19 and Related Developments
Table 61. Blinatumomab Distributors List
Table 62. Blinatumomab Customers List
Table 63. Covid-19 Impact on Blinatumomab Customers
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Blinatumomab Assessment
Table 9. COVID-19 Impact: Blinatumomab Market Trends
Table 10. COVID-19 Impact Global Blinatumomab Market Size
Table 11. Global Blinatumomab Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Blinatumomab Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Blinatumomab Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Blinatumomab Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Blinatumomab Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Blinatumomab Market Growth Drivers
Table 17. Global Blinatumomab Market Restraints
Table 18. Global Blinatumomab Market Opportunities
Table 19. Global Blinatumomab Market Challenges
Table 20. Key Manufacturers Blinatumomab Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Blinatumomab Market Size, 2019 (K Units) & (US$ Million)
Table 22. Blinatumomab Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Blinatumomab Manufacturing Plants
Table 24. Key Manufacturers Blinatumomab Market Served
Table 25. Date of Key Manufacturers Enter into Blinatumomab Market
Table 26. Key Manufacturers Blinatumomab Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Blinatumomab Market Size by Type, 2020, (US$ Million)
Table 29. Global Blinatumomab Market Size by Type, 2020 (K Units)
Table 30. Global Blinatumomab Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Blinatumomab Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Blinatumomab Market Size by Application, 2020-2021 (K Units)
Table 33. Global Blinatumomab Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Blinatumomab Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Blinatumomab Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Blinatumomab Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Blinatumomab Market Size, 2019-2021 (K Units)
Table 38. US Blinatumomab Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Blinatumomab Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Blinatumomab Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Blinatumomab Market Size, 2019-2021 (K Units)
Table 43. Germany Blinatumomab Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Blinatumomab Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Blinatumomab Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Blinatumomab Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Blinatumomab Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Blinatumomab Market Size, 2019-2021 (K Units)
Table 50. China Blinatumomab Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Blinatumomab Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Blinatumomab Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Blinatumomab Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Blinatumomab Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Blinatumomab Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Blinatumomab Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. Amgen Business Overview
Table 58. Amgen Blinatumomab Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Amgen Blinatumomab Product
Table 60. Amgen Response to COVID-19 and Related Developments
Table 61. Blinatumomab Distributors List
Table 62. Blinatumomab Customers List
Table 63. Covid-19 Impact on Blinatumomab Customers
LIST OF FIGURES
Figure 1. Blinatumomab Product Picture
Figure 2. Blinatumomab Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Blinatumomab Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Blinatumomab Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Blinatumomab Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Blinatumomab Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Blinatumomab Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Blinatumomab Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Blinatumomab Market Size Market Share, 2019-2021
Figure 1. Blinatumomab Product Picture
Figure 2. Blinatumomab Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Blinatumomab Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Blinatumomab Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Blinatumomab Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Blinatumomab Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Blinatumomab Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Blinatumomab Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Blinatumomab Market Size Market Share, 2019-2021
